Julien de Salaberry
Author
Julien is the CEO and co-founder of Galen Growth, the leading HealthTech intelligence, analytics, and matchmaking firm serving Fortune 500 companies and institutional investors. Julien is a change catalyst and evangelist who challenges the status quo in healthcare with his deep understanding of the world in which healthcare providers and organizations function. His passion and knowledge around profound technological innovation in transforming healthcare enable the necessary impetus for embracing the trend in the delivery of optimal patient care and health outcomes.
With over 15 years of experience in healthcare with leading brands including Lilly, Boston Scientific, Baxter, GSK, and Merck & Co, Julien has a deep understanding of organic and inorganic growth in healthcare in both developed and emerging markets. He has gained extensive international business experience across Europe, the Middle East, and Asia.
In 2012, he founded The Propell Group (TPG), a boutique venture investor firm based in Singapore, which focuses on HealthTech startups and growth companies. Since 2012, TPG has invested in 23 companies, including four successful exits.